Services
Advanced Clinical Diagnostics
At Metrodora Institute, advanced and comprehensive diagnostic testing provides key insights into every patient’s health and is a central part of our care approach. As a fully integrated medical and research institute, we have the expertise and technological capabilities to integrate leading scientific techniques into diagnosis and treatment. What we learn from your care improves care for you and for others.
Metrodora's advanced clinical diagnostic testing includes:
Genomics
Comprehensive genomics and deep immune profiling build a more complete picture of your health. This information provides us with important clues about how to accurately focus care. Our clinicians and genetic counselors work with you to understand what the results of genetic testing mean for you and your family.
Genomic testing we offer includes:
- Gene Panel Testing
- Whole Genome Sequencing (WGS)
- Long-Read DNA Sequencing
- DNA Methylation and Epigenetics Studies
- Pharmacogenomics
Advanced Immune Profiling
- Cytokine and Chemokine Profiling
- Autoantibody Detection
- Deep Immune Profiling
- Single Cell Studies
Multiomic Diagnostics
- Transcriptomics
- Proteomics
- Metabolomics
- Lipidomics
Other Testing
Microbiota (Microbiome) Testing
Clinical Trials
At Metrodora Institute, we are committed to supporting research studies evaluating new treatments for patients. As a Metrodora patient, you will have access to the latest and most advanced clinical trials.
Alpha Study (argenx) | Currently Enrolling
Metrodora is a clinical trial site for the argenx Alpha Study, which is investigating an existing therapeutic for the treatment of post-COVID postural orthostatic tachycardia (POTS).
For more information or to learn if you might be eligible for the study, please contact our Clinical Trials Program at [email protected]
Ready to start your patient journey?
Contact Information
Metrodora Institute
3535 South Market St.
West Valley City, UT
84119
Phone: (385) 430-1430
Now Enrolling
Metrodora is committed to supporting research studies evaluating new treatments for patients. We are a clinical trial site for the argenx Alpha Study, which is investigating an existing therapeutic for the treatment of post-COVID postural orthostatic tachycardia (POTS).
Contact our Clinical Trials Program